Journal article

Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction


Authors listBormann, Johanna; Psyrakis, Dimitrios A.; von Jeinsen, Beatrice; Gruen, Dimitri; Elsner, Laura K.; Wolter, Jan S.; Weferling, Maren; Diouf, Katharina; Kriechbaum, Steffen; Troidl, Christian; Doerr, Oliver; Nef, Holger; Hamm, Christian W.; Liebetrau, Christoph; Keller, Till

Publication year2020

Pages144-147

JournalInternational Journal of Cardiology

Volume number304

ISSN0167-5273

eISSN1874-1754

DOI Linkhttps://doi.org/10.1016/j.ijcard.2020.01.043

PublisherElsevier


Abstract

Myocardial infarction (MI) not only defines acute MI with obstructed coronary arteries (T1MI) but also myocardial necrosis caused by myocardial oxygen supply/demand mismatch as type 2 MI (T2MI); only T1MI patients benefit from an early invasive management. Myeloid-related protein(MRP)-8/14 is a biomarker described in various inflammatory diseases and in MI patients. Here we evaluate the potential of MRP-8/14 and high-sensitivity troponin I (hs-cTnI) to differentiate T2MI from T1MI.

Patients with final diagnosis NSTEMI (n = 254; 33.1% female) enrolled in a prospective biomarker registry between 08/2011 and 10/2016 were analysed. Median baseline MRP-8/14 levels were higher in T2MI (n = 55; 3.37(1.88-6.48)mu g/mL) than in T1MI ( n = 199; 2.4 [1.4-3.79]mu g/mL) (p = .013) patients, in contrast to hs-cTnI (T2MI:52[11.65-321.4]ng/L vs. T1MI:436.5 [61.25-1973.8]ng/L; p < .001). To detect the strength of this association odds ratios(OR) were calculated with MRP-8/14 yielding 2.13 (1.16-3.92; p = .015) to predict T2MI and 0.47(0.26-0.87; p = .015) for T1MI. As expected, hs-cTnI yielded an OR of to predict T2MI 0.34(0.17-0.65; p = .001) and 2.98(1.53-5.81; p = .001) for T1MI. Both markers show comparable and independent results if adjust to hs-cTnI/MRP-8/14, TIMI risk score and CRP.

T2MI is associated with higher MRP-8/14 and lower hs-cTnI concentrations than T1MI. Our data suggest that MRP-8/14 as a marker of inflammation might provide usable discriminatory information complementing hs-cTnI in a diagnostic procedure evaluating the type of MI directly upon hospital admission. (C) 2020 Elsevier B.V. All rights reserved.




Citation Styles

Harvard Citation styleBormann, J., Psyrakis, D., von Jeinsen, B., Gruen, D., Elsner, L., Wolter, J., et al. (2020) Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction, International Journal of Cardiology, 304, pp. 144-147. https://doi.org/10.1016/j.ijcard.2020.01.043

APA Citation styleBormann, J., Psyrakis, D., von Jeinsen, B., Gruen, D., Elsner, L., Wolter, J., Weferling, M., Diouf, K., Kriechbaum, S., Troidl, C., Doerr, O., Nef, H., Hamm, C., Liebetrau, C., & Keller, T. (2020). Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction. International Journal of Cardiology. 304, 144-147. https://doi.org/10.1016/j.ijcard.2020.01.043



Keywords


Myeloid-related protein 8/14MYELOID-RELATED-PROTEIN-8/14Myocardial infarctionRULE-OUTTroponinType 2 myocardial infarction

Last updated on 2025-21-05 at 18:23